Andere talen Xvivo Perfusion AB

Aandelen

XVIVO

SE0004840718

Beurs gesloten - Nasdaq Stockholm Andere beurzen 17:29:47 03-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
378 ^SEK	+2,02%		+1,34%	+14,72%

24/04	Transcript : Xvivo Perfusion AB, Q1 2024 Earnings Call, Apr 24, 2024
24/04	Xvivo Perfusion AB (publ) rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)	25/04
LE OPINIONI DEGLI ANALISTI DEL GIORNO : Moncler, Boreo, Fugro, STMicroelectronics, Alfen, Iberdrola, Roche, Temenos, Akzo Nobel...	25/04
AVIS D'ANALYSTES DU JOUR : Kering, Carrefour, STMicroelectronics, ArgenX, Ipsen, Accor, Moncler...	25/04
OPINIONES DE LOS ANALISTAS DEL DÍA : Aedas Homes, Almirall, STMicroelectronics, Enagás, Iberdrola, Roche, Temenos, Moncler...	25/04
Nordic Shares Declined Wednesday; Svenska Handelsbnkn Ser A Fell Furthest	24/04
Xvivo Perfusion AB Reports Earnings Results for the First Quarter Ended March 31, 2024	24/04
Estimates compiled by Modular Finance on behalf of XVIVO Perfusion.	19/04
Xvivo Perfusion : Results from XVIVO's clinical trial NIHP2019 for heart preservation presented at ISHLT in Prague	11/04
Results from XVIVO’s clinical trial NIHP2019 for heart preservation presented at ISHLT in Prague	11/04
Xvivo Perfusion AB Announces Results from Clinical Trial NIHP2019 for Heart Preservation Presented at ISHLT in Prague	11/04
Xvivo Perfusion : Notice to AGM 2024	21/03
Xvivo Perfusion : SORP 2024	21/03
Xvivo Perfusion : Styrelsens 19-22 redogörelse (Eng)	21/03
NOTICE TO ATTEND THE ANNUAL GENERAL MEETING IN XVIVO PERFUSION AB (PUBL)	21/03
Certain Shares of Xvivo Perfusion AB are subject to a Lock-Up Agreement Ending on 16-MAR-2024.	16/03
The first-ever transplantation with a donor heart transported across the Atlantic Ocean – made possible by the use of XVIVO’s heart technology	29/02
Nordic Shares Moved Upward Thursday; Nokia Topped Leaders	25/01
Les actions en mouvement : Vetoquinol et Teleperformance coulent, Vusiongroup et ID Logistics brillent	25/01
XVIVO presents Report on Operations 2023	25/01
Xvivo Perfusion AB Reports Earnings Results for the Full Year Ended December 31, 2023	25/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Xvivo Perfusion AB

Aandelen

XVIVO

SE0004840718

Andere talen

Filters